Correlation Between Molecular Partners and HCW Biologics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and HCW Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and HCW Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and HCW Biologics, you can compare the effects of market volatilities on Molecular Partners and HCW Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of HCW Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and HCW Biologics.
Diversification Opportunities for Molecular Partners and HCW Biologics
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Molecular and HCW is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and HCW Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HCW Biologics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with HCW Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HCW Biologics has no effect on the direction of Molecular Partners i.e., Molecular Partners and HCW Biologics go up and down completely randomly.
Pair Corralation between Molecular Partners and HCW Biologics
Given the investment horizon of 90 days Molecular Partners is expected to generate 18.52 times less return on investment than HCW Biologics. But when comparing it to its historical volatility, Molecular Partners AG is 5.55 times less risky than HCW Biologics. It trades about 0.02 of its potential returns per unit of risk. HCW Biologics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 42.00 in HCW Biologics on November 2, 2024 and sell it today you would lose (15.00) from holding HCW Biologics or give up 35.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. HCW Biologics
Performance |
| Timeline |
| Molecular Partners |
| HCW Biologics |
Molecular Partners and HCW Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and HCW Biologics
The main advantage of trading using opposite Molecular Partners and HCW Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, HCW Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HCW Biologics will offset losses from the drop in HCW Biologics' long position.| Molecular Partners vs. Surrozen | Molecular Partners vs. Armata Pharmaceuticals | Molecular Partners vs. Pasithea Therapeutics Corp | Molecular Partners vs. Aditxt Inc |
| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Molecular Partners AG | HCW Biologics vs. MediciNova |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |